Kondylakis Haridimos, Catalan Rocio, Alabart Sara Martinez, Barelle Caroline, Bizopoulos Paschalis, Bobowicz Maciej, Bona Jonathan, Fotiadis Dimitrios I, Garcia Teresa, Gomez Ignacio, Jimenez-Pastor Ana, Karatzanis Giannis, Lekadir Karim, Kogut-Czarkowska Magdalena, Lalas Antonios, Marias Kostas, Marti-Bonmati Luis, Munuera Jose, Nikiforaki Katerina, Pelissier Manon, Prior Fred, Rutherford Michael, Saint-Aubert Laure, Sakellariou Zisis, Seymour Karine, Trouillard Thomas, Votis Konstantinos, Tsiknakis Manolis
FORTH-ICS, Heraklion, Crete, Greece.
La Fe University and Polytechnic Hospital, La Fe Health Research Institute, Valencia, Spain.
Insights Imaging. 2024 May 31;15(1):130. doi: 10.1186/s13244-024-01711-x.
Artificial intelligence (AI) is revolutionizing the field of medical imaging, holding the potential to shift medicine from a reactive "sick-care" approach to a proactive focus on healthcare and prevention. The successful development of AI in this domain relies on access to large, comprehensive, and standardized real-world datasets that accurately represent diverse populations and diseases. However, images and data are sensitive, and as such, before using them in any way the data needs to be modified to protect the privacy of the patients. This paper explores the approaches in the domain of five EU projects working on the creation of ethically compliant and GDPR-regulated European medical imaging platforms, focused on cancer-related data. It presents the individual approaches to the de-identification of imaging data, and describes the problems and the solutions adopted in each case. Further, lessons learned are provided, enabling future projects to optimally handle the problem of data de-identification. CRITICAL RELEVANCE STATEMENT: This paper presents key approaches from five flagship EU projects for the de-identification of imaging and clinical data offering valuable insights and guidelines in the domain. KEY POINTS: ΑΙ models for health imaging require access to large amounts of data. Access to large imaging datasets requires an appropriate de-identification process. This paper provides de-identification guidelines from the AI for health imaging (AI4HI) projects.
人工智能(AI)正在彻底改变医学成像领域,有望将医学从被动的“疾病护理”模式转变为积极关注医疗保健和预防的模式。AI在这一领域的成功发展依赖于获取大量、全面且标准化的真实世界数据集,这些数据集要能准确代表不同人群和疾病。然而,图像和数据很敏感,因此,在以任何方式使用它们之前,需要对数据进行修改以保护患者隐私。本文探讨了五个欧盟项目在创建符合伦理规范且受通用数据保护条例(GDPR)监管的欧洲医学成像平台领域(专注于癌症相关数据)所采用的方法。它介绍了对成像数据进行去识别处理的具体方法,并描述了每个案例中遇到的问题及采取的解决方案。此外,还提供了经验教训,以便未来的项目能够最佳地处理数据去识别问题。关键相关性声明:本文介绍了来自五个欧盟旗舰项目对成像和临床数据进行去识别处理的关键方法,在该领域提供了有价值的见解和指导方针。关键点:用于健康成像的AI模型需要访问大量数据。访问大型成像数据集需要适当的去识别过程。本文提供了来自健康成像人工智能(AI4HI)项目的去识别指导方针。